Cystic fibrosis screening using the College panel: Platform comparison and lessons learned from the first 20,000 samples
暂无分享,去创建一个
Weimin Sun | C. Strom | Ben Anderson | B. Crossley | J. Redman | A. Buller | Donghui Huang | T. Entwistle
[1] E. Girodon,et al. Frequent Occurrence of the CFTR Intron 8 (TG)n 5T Allele in Men with Congenital Bilateral Absence of the Vas Deferens , 1995, European journal of human genetics : EJHG.
[2] J. Haddow,et al. Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians , 2002, Genetics in Medicine.
[3] E. Buratti,et al. Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. , 1999, Human molecular genetics.
[4] Ronald G. Crystal,et al. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA , 1993, Nature Genetics.
[5] M Claustres,et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. , 1995, The New England journal of medicine.
[6] B. Kerem,et al. The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. , 1997, American journal of human genetics.
[7] R. Heim,et al. Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel , 2001, Genetics in medicine : official journal of the American College of Medical Genetics.
[8] K. Klinger,et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening , 2001, Genetics in Medicine.
[9] C. Férec,et al. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling , 2001, Human Genetics.